Currently out of the existing stock ratings of Taylor Feehley, 3 are a BUY (75%), 1 are a HOLD (25%).

Taylor Feehley

Work Performance Price Targets & Ratings Chart

Analyst Taylor Feehley, carries an average stock price target met ratio of 50% that have a potential upside of 13.09% achieved within 19 days.

Taylor Feehley’s has documented 7 price targets and ratings displayed on 2 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on SYBX, Synlogic at 29-Mar-2023.

Wall Street Analyst Taylor Feehley

Analyst best performing recommendations are on MCRB (SERES THERAPEUTICS).
The best stock recommendation documented was for MCRB (SERES THERAPEUTICS) at 9/18/2020. The price target of $560 was fulfilled within 11 days with a profit of $47 (9.16%) receiving and performance score of 8.33.

Average potential price target upside

SYBX Synlogic MCRB Seres Therapeutics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Sell

$5

1 years 8 months 10 days ago
(09-Feb-2024)

6/6 (100%)

$-2.65 (-34.64%)

96

Hold

$1

$-0.83 (-45.36%)

$8

1 years 8 months 11 days ago
(08-Feb-2024)

4/5 (80%)

$-0.77 (-43.50%)

404

Hold

1 years 8 months 11 days ago
(08-Feb-2024)

0/1 (0%)

$94.35 (169.54%)

Buy

$300

2 years 6 months 20 days ago
(29-Mar-2023)

0/1 (0%)

$186.9 (165.25%)

Buy

3 years 2 days ago
(17-Oct-2022)

0/1 (0%)

$127.05 (88.88%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Taylor Feehley?

On 2018

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?